Reading rule
Agency claim or final finding?
An FDA warning letter states the agency’s allegations at a point in time; it is not a final finding, and later events can change the record.
Open official sourceEvidence reader
How to read peptide claims without getting spun
Sellers often take one true fact, such as “registered with FDA”, and use it to suggest something bigger, such as “approved by FDA”.
Rules checked: September 2026.
Read the full phrase
An FDA-registered outsourcing facility has completed a registration step; that status does not approve the facility or any medicine it makes.
Ask what the statement is really about: the building where medicine is made, one ingredient, or the finished medicine you would take.
Compounded is not generic
A compounded preparation is not FDA-approved and cannot honestly be presented as the FDA-approved generic version of a brand medicine.
As of September 2026, no generic version of Ozempic, Wegovy, Mounjaro or Zepbound could be sold in the United States.
A shortage is a federal listing
A local out-of-stock notice is not the same as a national FDA drug-shortage listing.
Neither semaglutide nor tirzepatide appeared on FDA’s drug-shortage list as of September 2026.